NEW YORK, NY (August 14, 2023) — A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study led by researchers at Weill Cornell Medicine, the New York Genome Center and the Princess Margaret Cancer Centre in Toronto. A better understanding […]
NEW YORK, NY (July 26, 2023) – In May of 2023, the US National Institutes of Health (NIH) announced the Somatic Mosaicism across Human Tissues (SMaHT) program. Funded by the NIH Common Fund with $140 million over five years, the SMaHT program is a trans-NIH initiative dedicated to surveying the diversity of genomes of different […]
NYGC research teams will work to accelerate our knowledge of the genetic variation within cells and tissues of the human body NEW YORK, NY (May 11, 2023) – The National Institutes of Health (NIH) Common Fund has selected the New York Genome Center (NYGC) as a multi-grant recipient under the Somatic Mosaicism across Human Tissues […]
NEW YORK, NY (January 2, 2023) — A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented resolution, according to a study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and the New York Genome Center. The method, described Jan. 2 in a paper in Nature […]
